Lots of discussion about lack of advancement in women's health
Here is the thing. We will NOT advance reproductive/pregnancy/women's health science by continuing to do clinical trials that are NOT based on fundamental mechanisms that drive health & disease
hang on...🧵🧵🧵
1/
Let me explain:
Millions (millions)💲 have been spent to perform clinical trials to decrease adverse pregnancy outcomes such as #preeclampsia
Trials on Vitamin C, E, magnesium, aspirin, calcium
Perhaps, you might be thinking--those are pretty generic interventions 👀
2/
And you would be right. They are.
Vit C & E clinical trial was based on concept that there is evidence of oxidative stress in placentas from preeclamptic individuals
OK. Yes, but oxidative stress is a pretty ubiquitous biological event
3/
and no data saying ox stress was a KEY event in the development of preeclampsia
Fact: We remain uninformed regarding the key molecular pathways that lead to preeclampsia
Fact: Until we know this, clinical trials will *guess* at best intervention.
But, there is more
(sigh)
4/
Let's take #pretermbirth. Lots of clinical trials. Many (most?) focused on progesterone and cerclage (stitch to close the cervix)
Shall we start with progesterone?
In pregnancy, LOTs of progesterone. Its the job of corpus luteum and then placenta
5/
but somewhere along the way (see 1960s & before), idea that not enough PROG so supplementation would prevent preterm birth.
And, so, clinical trials giving PROG by mouth, my shot, my suppository
By rule of stats, we should have a few trials that showed positive outcome.
6/
And we did....along with so many more that have shown no benefit.
FACT: We do not know why vaginal progesterone prevents preterm birth (in studies where it did). I have researched this and yeah, I could not find a molecular mechanism.
7/
So, put a stitch in it?!!?
Cerclages got started because clinically the cervix appeared to 'open' without cause.
You know what the pregnant cervix is?
an incredible organ that has distinct immune, molecular AND BIOMECHANICAL properties.
Ask me what a stitch does to those
8/
👀
Now, that is just 2 examples regarding pregnancy outcomes.
But, it is ALL. OF. WOMEN'S. HEALTH
Let me list a few of the conditions that that we have INSUFFICIENT knowledge regarding the mechanisms that drive these conditions
9/
How the "I am pro-choice but" is about so much more
This 'argument' stems from the same misogynistic narrative that leads to
"but she was wearing a really short skirt" explaining why she was sexually assaulted
"but she is difficult" excusing why she was harassed at work 1/
It is a narrative (belief) that women are less. It is the narrative that they are of less value than men, that they are underserving of bodily autonomy.
This narrative, this belief is what drives, in the year 2022, rising rates of maternal mortality 2/
it is what drives the lack of advancement & improvement of outcomes for gynecological cancers
it is what drives the failure to innovate any new and better treatments for the multitude consequences of menopause 3/
On 6/24/2022, when #Roe was overturned, I wrote a letter to those that I do research with. I have been asked to share that broadly. I know others in academia are afraid (for legitimate reasons) to share their voice. I am not unafraid but I have committed to not being silent 1/
the letter:
Friends and colleagues-
I have or am currently working with everyone on this email in various and important ways to advance reproductive & maternal health. In this pursuit & in my role as colleague, mentor, advisor, grant editor, etc, I feel beholden to send this 2/
I apologize for the mass email but I think one of the reasons that we are in this dire situation today is because the collective we are often too silent about those people and processes—‘outside of medicine’—that affect the health of women. 3/
In the debate of academia or nah. Let me offer this. If you want to support & foster physician-scientists & by doing that advance science & health
Here is a short list of things NOT TO SAY & things TO DO🧵
Do NOT say this 1) The department loses $ on YOU 2) your K cost us $
3) why can’t you cover, you are just on research time? 4) protected doesn’t mean you ALWAYS get that time 5) you submitted grants but they didn’t get funded 6) you should find a mentoring team 7) call doesn’t count in your effort 8) BUT, clinical folks are working so much harder
DO THIS (leaders) 1) Set up transparency on how you (leaders) will fund & support their research efforts for 3-5 years and then continue to do so by years (e.g. 3) for continuity & productivity. If you can’t fund them, then don’t say you can support. Let them find better options
#MFMmonday: THEREAPEUTICS in OBSTETRICS
Imperative reads: review & clinical opinion in July issue of @AJOG_thegray focused on developing drugs for pregnancy use. When reading, consider COVID vax & pregnant population
A mini tweetorial
The reviews introduce the history and the problem
from limitations in scientific discovery, to uninterested industry to regulatory constraints
These are not questionable obstacles; the issue is what have we done to change the narrative & importance
Stated: " for example, only 5% of women develop GDM, hardly justifying the cost and regulatory burden of drug approval"
🤔
For your consideration, the prevalence of benign prostatic hypertrophy in 4th decade is 8%
I posted this after a long, tearful discussion with a dear friend.
She is a dedicated doc and an amazing scientist. She played within the system- for years.